Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update
Morgan Rouprêt, Thomas Seisen, Alison Birtle, et al.
European Urology (2023) Vol. 84, Iss. 1, pp. 49-64
Open Access | Times Cited: 284

Showing 1-25 of 284 citing articles:

Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review
Achille Aveta, Simone Cilio, Roberto Contieri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10846-10846
Open Access | Times Cited: 54
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial
Alison Birtle, Robert J. Jones, John Chester, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1466-1471
Open Access | Times Cited: 31
Upper Tract Urothelial Cancer: Guideline of Guidelines
Savio Domenico Pandolfo, Simone Cilio, Achille Aveta, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1115-1115
Open Access | Times Cited: 17
Case report: A rare case of delayed drug-induced hyponatremia in recurrent upper tract urothelial carcinoma following GC and Tislelizumab treatment
Zhijie Wang, Yan Nie, Shi-Bing Liang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets
Francesco Claps, Nicola Pavan, Luca Ongaro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12596-12596
Open Access | Times Cited: 31
Urinary Micro-RNAs As Biomarkers of Urological Cancers: A Systematic Review
Achille Aveta, Simone Cilio, Roberto Contieri, et al.
(2023)
Open Access | Times Cited: 30
Systemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective
Robert J. Jones, Simon J. Crabb, Mark Linch, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 6, pp. 897-907
Open Access | Times Cited: 12
The correlation between discrepancies in clinical and pathological T stages and overall survival in upper urinary tract urothelial carcinoma: Analysis of the hospital‐based cancer registry data in Japan
Makiko Shiga, Yoshiyuki Nagumo, Kosuke Kojo, et al.
International Journal of Urology (2025)
Closed Access | Times Cited: 1
Intravesical Instillation of Chemotherapy Before Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: The REBACARE Trial
Thomas van Doeveren, Sebastiaan Remmers, Egbert R. Boevé, et al.
European Urology (2025)
Open Access | Times Cited: 1
Clinical and molecular analysis of JCPyV and BKPyV infection and associated risk of urothelial carcinoma development in the upper tract
Chun‐Nun Chao, Chi‐Feng Hung, Wei‐Hong Lai, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Ferrous Selenide Stabilized Black Phosphorus Heterojunction Sonosensitizer for MR Imaging-Guided Sonodynamic Therapy of Bladder Cancer
Sicheng Wu, Guanlin Li, Wenrui Ouyang, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 6
Development and validation of an artificial intelligence-based model for detecting urothelial carcinoma using urine cytology images: a multicentre, diagnostic study with prospective validation
Shaoxu Wu, Runnan Shen, Guibin Hong, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102566-102566
Open Access | Times Cited: 6
Trifecta Outcomes of Robot-Assisted Partial Nephrectomy Using the New Hugo™ RAS System Versus Laparoscopic Partial Nephrectomy
Francesco Prata, Alberto Ragusa, Francesco Tedesco, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2138-2138
Open Access | Times Cited: 6
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy
Sean A. Fletcher, Maximilian Pallauf, Emelia Watts, et al.
European Urology Oncology (2024) Vol. 7, Iss. 5, pp. 1061-1068
Closed Access | Times Cited: 5
Single-cell and multi-omics analyses highlight cancer-associated fibroblasts-induced immune evasion and epithelial mesenchymal transition for smoking bladder cancer
Jiajin Wu, Fang Gao, Rui Meng, et al.
Toxicology (2024) Vol. 504, pp. 153782-153782
Closed Access | Times Cited: 5
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study)
Ondřej Fiala, Sebastiano Buti, Aristotelis Bamias, et al.
Targeted Oncology (2024) Vol. 19, Iss. 4, pp. 587-599
Open Access | Times Cited: 5
Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function
Patrick J. Hensley, Craig Labbate, Andrew Zganjar, et al.
European Urology Oncology (2024)
Open Access | Times Cited: 4
Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma
Surena F. Matin, Mehrad Adibi, Amishi Y. Shah, et al.
The Journal of Urology (2024) Vol. 211, Iss. 6, pp. 784-793
Closed Access | Times Cited: 4
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project
Alessandro Rizzo, Sebastiano Buti, Patrizia Giannatempo, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 5, pp. 655-665
Closed Access | Times Cited: 4
If not now, then when? The need for new evidence in the robotic management of upper tract urothelial carcinoma
Fabrizio Di Maida, Carlo Andrea Bravi, Ruben De Groote, et al.
Minerva Urology and Nephrology (2024) Vol. 76, Iss. 5
Closed Access | Times Cited: 4
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial Cancer
Toru Sakatani, Takayuki Sumiyoshi, Yuki Kita, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Single bladder instillation of gemcitabine versus mitomycin C after minimally invasive radical nephroureterectomy: A propensity-score match analysis from the ROBUUST 2.0 collaborative group
Eugenio Bologna, Zhenjie Wu, Antonio Franco, et al.
Asian journal of urology (2025)
Open Access
Drug classes associated with the development of fulminant type 1 diabetes: a retrospective analysis using the FDA adverse event reporting system database
Yang Zhou, Yupeng Chen, Shan Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Application of Raman Spectroscopy in the Non-invasive Diagnosis of Urological Diseases via Urine
Ailiyaer Ainiwaer, Shuwen Sun, Ayinuer Bohetiyaer, et al.
Photodiagnosis and Photodynamic Therapy (2025) Vol. 52, pp. 104477-104477
Open Access
Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions
Sandra McDonald, K.G. Keane, Richard Gauci, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 232-232
Open Access
Page 1 - Next Page

Scroll to top